New Clinical Indications for 18 F/ 11 C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature
Journal article published in 2016 by
Laura Evangelista,
Alberto Briganti,
Stefano Fanti,
Stephen Joniau,
Sven Reske,
Riccardo Schiavina,
Christian Stief,
George N. Thalmann,
Maria Picchio 
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Radiolabelled choline positron emission tomography has changed the management of prostate cancer patients. However, new emerging radiopharmaceutical agents, like radiolabelled prostate specific membrane antigen, and new promising hybrid imaging will begin new challenges in the diagnostic field.